125
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Retinoblastoma-associated protein 140 as a candidate for a novel etiological gene to hypertension

, &
Pages 533-540 | Received 27 Nov 2015, Accepted 09 Feb 2016, Published online: 08 Jul 2016
 

ABSTRACT

Gene discovery in animal models may lead to the revelation of therapeutic targets for essential hypertension as well as mechanistic insights into blood pressure (BP) regulation. Our aim was to identify a disease-causing gene for a component of polygenic hypertension contrasting inbred hypertensive Dahl salt-sensitive (DSS) and normotensive Lewis rats. The chromosome segment harboring a quantitative trait locus (QTL), C16QTL, was first isolated from the rat genome via congenic strains. A candidate gene responsible for C16QTL causing a BP difference between DSS and Lewis rats was then identified using molecular analyses combining our independently-conducted total genome and gene-specific sequencings. The retinoblastoma-associated protein 140 (Rap140)/family with sequence similarity 208 member A (Fam208a) is the only candidate gene supported to be C16QTL among three genes in genome block 1 present in the C16QTL-residing interval. A mode of its actions could be to influence the expressions of genes that are downstream in a pathway potentially leading to BP regulation such as that encoding the solute carrier family 7 (cationic amino acid transporter, y+ system) member 12 (Slc7a12), which is specifically expressed in kidneys. Thus, Rap140/Fam208a probably encoding a transcription factor is the strongest candidate for a novel BP QTL that acts via a putative Rap140/Fam208a–Slc7a12-BP pathway. These data implicate a premier physiological role for Rap140/Fam208 beyond development and a first biological function for the Slc7a12 protein in any organism.

Declaration of interest

The authors have no conflict of interest.

Funding

The authors are grateful for a grant from Canadian Institutes for Health Research (CIHR) to AYD and a doctoral fellowship to KC (Fond de Recherche en Sante du Quebec).

Supplementary material

Supplemental data for this article can be accessed on the publisher’s website

Additional information

Funding

The authors are grateful for a grant from Canadian Institutes for Health Research (CIHR) to AYD and a doctoral fellowship to KC (Fond de Recherche en Sante du Quebec).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.